Jump Financial’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.09M Buy
+87,440
New +$2.58M 0.02% 712
2025
Q3
Sell
-18,592
Closed -$210K 2167
2025
Q2
$210K Buy
18,592
+3,622
+24% +$39.3K ﹤0.01% 1593
2025
Q1
$151K Buy
14,970
+3,553
+31% +$38.4K ﹤0.01% 1472
2024
Q4
$135K Buy
+11,417
New +$135K ﹤0.01% 1525
2023
Q4
Sell
-416,667
Closed -$4.87M 2176
2023
Q3
$4.87M Buy
+416,667
New +$4.71M 0.18% 114
2023
Q1
Sell
-166,204
Closed -$1.33M 1985
2022
Q4
$1.33M Buy
+166,204
New +$925K 0.07% 379
2022
Q2
Sell
-41,243
Closed -$203K 1966
2022
Q1
$203K Buy
+41,243
New +$272K 0.01% 1298

Other funds holding ROIV

Jump Financial's ROIV Position: Q2 2026 in Review

Jump Financial opened a new position in Roivant Sciences (ROIV) in Q2 2026: 87,440 shares worth $3.09M. The stake represents 0.02% of the portfolio and ranks #712 among its holdings. This is a return to the name: Jump Financial previously reported a position in ROIV as recently as Q2 2025.

Jump Financial first reported a position in ROIV in Q1 2022 and has held it in 7 quarters since. The position peaked at $4.87M in Q3 2023. 500 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Jump Financial held 87,440 shares of Roivant Sciences worth $3.09M as of Q2 2026.
  • Roivant Sciences was a new Jump Financial position in Q2 2026.
  • Roivant Sciences made up 0.02% of Jump Financial's portfolio in Q2 2026, its #712 holding.
  • Jump Financial first reported a position in Roivant Sciences in Q1 2022 and has held it in 7 quarters since.
  • Jump Financial's Roivant Sciences position peaked at $4.87M in Q3 2023.
  • 500 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.